Ocugen Inc. Stock Falls Tuesday, Underperforms Market

MarketWatchDec 25 06:36

Express News | Ocugen Inc - Dsmb Approves Continuation of Ocu410 Armada Phase 1/2 Study

BreakingsDec 19 19:38

Express News | Ocugen Inc: Ocu410 Has a Very Favorable Safety and Tolerability Profile

BreakingsDec 19 19:38

Express News | Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of Ocu410 Armada Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

BreakingsDec 19 19:38

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

OcugenDec 19 13:00

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

OcugenDec 11 13:00